Showing results (1601-1610 of 1,742) with videos related to
Sort By:
Pageof 175
Age and Ageing|December 7, 2025
The association between dispositional optimism and functioning and quality of life in older patients 12 months after cancer diagnosis: a multicentre cohort studyAnna Uit Den Boogaard, Stella Trompet, Marjan Van Der Elst, et al.Thescientificworldjournal|September 27, 2021
Associations of Air Pollution and Pediatric Asthma in Cleveland, OhioSumita B Khatri, Cynthia Newman, Jeffrey P Hammel, et al.Drugs & Aging|May 10, 2024
Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational StudyEstelle Tran Van Hoi, Stella Trompet, Yara Van Holstein, et al.American Journal of Physiology. Heart and Circulatory Physiology|November 24, 2023
Cardiovascular autonomic nervous function in children conceived by assisted reproductive technology with frozen or fresh embryo transferIkram Mizrak, Morten A V Lund, Ann V Landgrebe, et al.Nature Communications|April 10, 2024
Integrated proteomics reveals autophagy landscape and an autophagy receptor controlling PKA-RI complex homeostasis in neuronsXiaoting Zhou, You-Kyung Lee, Xianting Li, et al.Therapeutic Advances in Hematology|December 2, 2024
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiaryCarmen Escuriola Ettingshausen, Wolfgang Eberl, Hermann Eichler, et al.Journal of Neurotrauma|April 27, 2019
A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal ExcitabilityVladislav Bugay, Eda Bozdemir, Fabio A Vigil, et al.Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.Scientific Reports|March 15, 2017
Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activationJürgen Brück, Julia Holstein, Ivana Glocova, et al.Pageof 175